Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record.

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study

Open access
Su, X, Zhan, P, Gavine, P R, Morgan, S, Womack, C, Ni, X, Shen, D, Bang, Y-J, Im, S-A, Ho Kim, W, Jung, E-J, Grabsch, H I, Kilgour, E·2014·British Journal of Cancer

Abstract

BACKGROUND: In preclinical gastric cancer (GC) models, FGFR2 amplification was associated with increased tumour cell proliferation and survival, and drugs targeting this pathway are now in clinical trials. METHODS: FGFR2 FISH was performed on 961 GCs from the United Kingdom, China and Korea, and the relationship with clinicopathological data and overlap with HER2 amplification were analysed. RESULTS: The prevalence of FGFR2 amplification was similar between the three cohorts (UK 7.4%, China 4.6% and Korea 4.2%), and intratumoral heterogeneity was observed in 24% of FGFR2 amplified cases. FGFR2 amplification was associated with lymph node metastases (P<0.0001). FGFR2 amplification and polysomy were associated with poor overall survival (OS) in the Korean (OS: 1.83 vs 6.17 years, P=0.0073) and UK (OS: 0.45 vs 1.9 years, P<0.0001) cohorts, and FGFR2 amplification was an independent marker of poor survival in the UK cohort (P=0.0002). Co-amplification of FGFR2 and HER2 was rare, and when high-level amplifications did co-occur these were detected in distinct areas of the tumour. CONCLUSION: A similar incidence of FGFR2 amplification was found in Asian and UK GCs and was associated with lymphatic invasion and poor prognosis. This study also shows that HER2 and FGFR2 amplifications are mostly exclusive.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.2013.802

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 190

Metadata

Authors
Su, X., Zhan, P., Gavine, P. R., Morgan, S., Womack, C., Ni, X., Shen, D., Bang, Y.-J., Im, S.-A., Ho Kim, W., Jung, E.-J., Grabsch, H. I., & Kilgour, E.
Venue
British Journal of Cancer
Published
2014-01-23
Volume
110
Issue
4
Pages
967-975
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2005792607
Cited by
190
References
0
FWCI
18.66
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. https://app.cochat.ai/papers/10.1038/bjc.2013.802
The paper
Su, X., Zhan, P., Gavine, P. R., Morgan, S., Womack, C., Ni, X., Shen, D., Bang, Y.-J., Im, S.-A., Ho Kim, W., Jung, E.-J., Grabsch, H. I., & Kilgour, E. (2014). FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. British Journal of Cancer. https://doi.org/10.1038/bjc.2013.802

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.